H.R. 2821 Congress 119 session
FDA Modernization Act 3.0
FDA Modernization Act 3.0 This bill requires the Food and Drug Administration (FDA) to publish an interim final rule implementing a provision of the Consolidated Appropriations Act of 2023 that authorized the use of certain alternatives to animal testing to support investigational use of a new drug. The rule must replace references to animal tests, data, studies, models, and research with references to nonclinical tests, data, studies, models, and research throughout the FDA’s regulations governing investigational new drug applications. The rule must be published within one year of the bill’s enactment, and must take immediate effect as an interim final rule.
Status
- Introduced
- Committee
- Floor vote
- Passed
- Enacted
Passed one chamber — last recorded action July 21, 2026
Received in the Senate.
Passage likelihood
95% Higher than most bills at this stage
This is an estimate, not a guarantee. It is computed from the signals listed below and nothing else. It does not account for leadership priorities, floor scheduling, or negotiations that are not in the public record.
What the estimate is based on
- Historical base rate About 4% of introduced federal bills are enacted.
- Current stage Passed one chamber.
- Cosponsors 41 cosponsors.
- Bipartisan cosponsorship Cosponsors come from 2 parties.
State-level impact
State-level impact data is not available for this bill. The source text does not contain a per-state funding formula or scored breakdown, so no figures are shown.
Official actions
- Received in the Senate.
- Motion to reconsider laid on the table Agreed to without objection.
- On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639)
- Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639)
- DEBATE - The House proceeded with forty minutes of debate on H.R. 2821.
- Considered under suspension of the rules. (consideration: CR H4639-4640)
- Mr. Guthrie moved to suspend the rules and pass the bill.
- Placed on the Union Calendar, Calendar No. 614.
- Reported by the Committee on Energy and Commerce. H. Rept. 119-706.
- Reported by the Committee on Energy and Commerce. H. Rept. 119-706.
- Ordered to be Reported by the Yeas and Nays: 44 - 0.
- Committee Consideration and Mark-up Session Held
- Forwarded by Subcommittee to Full Committee by Voice Vote.
- Subcommittee Consideration and Mark-up Session Held
- Referred to the Subcommittee on Health.
- Referred to the House Committee on Energy and Commerce.
- Introduced in House
- Introduced in House